News, Scientific publications and Events

Barrier Technology Gastroenterology News GELSECTAN®

GELSECTAN® launched in Finland

We are glad to announce the launch of GELSECTAN® in Finland by our partner company Sabora. GELSECTAN® belongs to a new class of products defined as “mucosal protectors”, which help restore the normal function of the epithelial barrier in the gut. It is intended to relieve and prevent IBS symptoms such as chronic or relapsing diarrhea, pain and bloating.

Barrier Technology Gastroenterology Pediatrics News

Xilaplus® launched in France by Therabel

Noventure is proud to announce the launch of XILAPLUS® in France by its long-term partner company Therabel, under the brand name Diastil Diarrhée. XILAPLUS® is specifically formulated for the control and reduction of diarrheal events of various etiologies. It acts by forming a film which protects the intestinal mucosa, reducing the frequency and duration of diarrhea episodes and associated symptoms in adults, children, and infants.

Gastroenterology Pediatrics Scientific Publication TASECTAN®

Efficacy of gelatin tannate for acute diarrhea in children: a systematic review and meta-analysis.

Publication of a systematic review and meta-analysis on the efficacy of gelatin tannate in acute diarrhea in children. Aim: To investigate by meta-analysis the efficacy of gelatin tannate (GT), a mucosal barrier protector, in children with acute gastroenteritis. Conclusion: GT significantly (p < 0.01) reduced stool frequency at 12 h as well as the number of patients with diarrhea or liquid stools at 24 h (p < 0.01), compared with placebo. No adverse events were reported in any of the RCTs analyzed. The unique mechanism and lack of systemic absorption of GT make this device an interesting addition to the current armamentarium for treating acute gastroenteritis in children.